All posts by imreal

New Web AR Innovation Brings 4K Video Content To Life In Augmented Reality


Ultra-high resolution video content unlocks higher quality Web AR experiences such as portals, OOH AR video ads, AR posters and print marketing.

Web AR agency, Aircards launches 4K video enabled Web AR experiences through adaptive streaming of high-resolution video content in Web-based Augmented Reality. The proprietary software uses a similar approach to buffering video on platforms such as Youtube and Netflix, effectively eliminating the limit of video duration for content and significantly reducing experience load times.

This proprietary feature developed by the Aircards team is a significant breakthrough in the realm of WebAR.

Why is this a breakthrough?

Due to the nature of Web AR as a cloud-hosted technology where users access experiences through a standard webpage, video content previously needed to be compressed to optimize file size for speedy page-load time. This constraint typically restricted the use of 4K resolution video due to the extremely large file size, but this new feature from Aircards removes that constraint. Ultra-high resolution video content unlocks higher-quality WebAR experiences such as portals, OOH AR video ads, and AR posters.

COO of Aircards, Michael Watson said:

“We’re proud to continually lead the charge on innovation within the Web AR space. Our team has developed an approach to enable adaptive streaming of high-resolution video content up to 4K in AR.”

“Our proprietary software uses a similar approach to buffering video on platforms such as Youtube and Netflix, effectively eliminating the limit of video duration for content in AR and reducing initial page load times by over 10x.”

Not only does this enable enhanced video resolution, it enables unlimited video duration for experiences where a longer video is preferential.

The proprietary technology, named ‘4K-AR’ uses adaptive bitrate streaming, which is the ability to download video segments during playback, and to adjust video quality in the middle of a stream as network conditions change while viewing the Web AR experience.

Aircards solely develop and deploy using the 8th Wall Web AR framework, which allows client campaigns to be totally ‘app-less’, meaning users don’t need to download an app to view the experience. 4K-AR is compatible across both iOS and Android devices and is now available for use within client campaigns.

Share article on social media or email:

The Private Clinic back open again following Covid-19 Lockdown, Virtual consultations available to discuss treatment options with their selected surgeons


The Private Clinic of Harley Street are a leading Cosmetic Surgery provider who have over 35 years of experience in Medical Cosmetic procedures and advanced non-surgical treatments.

With clinics located across the UK, they have a team of world-class top specialists in Cosmetic & Plastic Surgery, Body Contouring & Liposuction, Hair Transplants & Restoration, Breast Surgery and Aesthetics/Rejuvenation & Dermatology for Men and Women.

The multi award winning company is starting to gradually open its doors again to patients after closing for over 3 months during the Covid-19 lockdown.

The Private Clinic has one of the highest patients’ satisfaction rates with a Trustpilot 9.4, 5 star rating and 96% of patients would recommend them to their friends and family.

The London Harley Street flagship clinic was established in 1983 and they now have clinics located nationwide in Birmingham, Manchester, Buckinghamshire, Northampton, Bristol and Leeds.They are able to offer patients a wide range of procedures including:

Cosmetic Surgery

The Private Clinic offers a full range of plastic surgery procedures performed by world class plastic surgeons. Procedures include Breast Augmentation, Rhinoplasty, Abdominoplasty and Ear Reshaping many of which are performed at our privately owned state of the art hospital in central London.

Body Contouring

An area of excellence for The Private Clinic is their range of liposuction and body contouring procedures. Patients are able to choose from a variety of liposuction techniques including vaser lipo, hi-def lipo and micro lipo. They also offer non-surgical fat reduction treatment CoolSculpting.

Varicose Vein removal

Varicose vein removal treatments at The Private Clinic are performed by experienced vascular surgeons offering the NICE (National Institute for Clinical Excellence) Gold Standard for treatment of Varicose Veins; Endovenous Laser Ablation which has an impressive 95.4% success rate after five years.

Hair Restoration

The Private Clinic hosts many industry leading hair transplant surgeons who offer the most advanced and minimally-invasive FUE Hair Transplant techniques available today. Patients can be sure that they are in the best of hands for this life changing procedure.

Bunion Removal

Bunion removal was previously a painful procedure with extensive downtime. The Private Clinic have revolutionised this treatment with their experienced Orthopaedic Consultant Surgeon offering a quick mini-invasive surgical procedure. The minimally invasive bunion removal treatment doesn’t involve any fixative devices such as screws, plates or wires meaning after treatment patients are able to walk immediately with no crutches and return to their everyday activities within weeks.

Skin Rejuvenation

The Private Clinic has a professional team of doctors, nurses and nurse prescribers offering patients a range of skin rejuvenation treatments including anti-wrinkle injections, dermal fillers and thread lifts. An expert team of skin practitioners are knowledgeable in offering treatments to help with many common skin concerns from acne to pigmentation and rosacea.

Virtual Consultations

During the Covid-19 lockdown, The Private Clinic have worked extensively to ensure that they offer patients the same first-class service with social distancing restrictions in place. Virtual consultations are available for many of their treatments allowing patients to discuss treatment options with their selected surgeons before making the decision to proceed with their journey and visit in-person.

To find out more about The Private Clinic visit their website at http://www.theprivateclinic.co.uk.

Share article on social media or email:

Shady Grove Fertility (SGF) Celebrates Maryland’s Revised Fertility Insurance Laws that Increase Access to Care for More Families


Shady Grove Fertility (SGF) is proud to support the revisions to Maryland’s insurance laws that increase access to care for those seeking fertility treatment.

Effective January 1, 2021, Maryland’s infertility insurance law no longer has a marriage requirement, and the 2-year “waiting” period has been reduced to 1 year of unprotected sexual intercourse or three attempts of artificial insemination in the course of a year.

Shady Grove Fertility (SGF) is proud to support the revisions to Maryland’s insurance laws that increase access to care for those seeking fertility treatment. Effective January 1, 2021, Maryland’s infertility insurance law no longer has a marriage requirement, and the 2-year “waiting” period has been reduced to 1 year of unprotected sexual intercourse or three attempts of artificial insemination in the course of a year.

SGF applauds RESOLVE: The National Infertility Association, of whom Shady Grove Fertility is a visionary partner, for their advocacy work. The Governor and the Maryland legislature are updating the state’s insurance law—which was the first infertility insurance law in the country in 1985—to cover unmarried patients and more closely align with the guidelines of the American Society for Reproductive Medicine (ASRM).

Many Marylanders have an advantage over residents of other states when it comes to infertility insurance legislation, known as the Maryland Mandate, as Maryland was the first state in the nation to enact infertility insurance legislation and was the third state that also covers fertility preservation prior to cancer treatment.

Currently, 19 states have passed laws that require health insurance coverage be offered for or actually cover an infertility diagnosis and/or fertility treatment, and ten states have fertility preservation laws for iatrogenic, or medically induced, infertility. Read more about State Fertility Insurance Laws.

Over 90 percent of SGF patients with insurance have coverage for their initial consult, and at least 70 percent have some level of coverage for testing and/or treatment. For those without adequate insurance coverage, SGF offers unique financial programs such as its Shared Risk 100% Refund Program, which guarantees patients take home a baby or receive 100% refund, and income-based Shared Help Program, among other discount programs, that aim to make treatment affordable to all.

To learn more about Maryland’s family building advocacy efforts, visit RESOLVE.

To learn more or to schedule a virtual physician consultation with an SGF physician, call 1-888-761-1967 or visit ShadyGroveFertility.com.

About Shady Grove Fertility (SGF)

SGF is a leading fertility and IVF center of excellence with more than 85,000 babies born and counting. With 38 locations throughout FL, GA, MD, NY, PA, VA, D.C., and Santiago, Chile, we offer patients virtual physician consults, individualized care, accept most insurance plans, and make treatment affordable through innovative financial options, including treatment guarantees. More physicians refer their patients to SGF than any other center. Call 1-888-761-1967 or visit ShadyGroveFertility.com.

Share article on social media or email:

Gateway Genomics Announces Top 7 Reasons Why Women Want to Know Their Baby’s Gender Early


SneakPeek Early Gender DNA Test

In pregnancy, there are many unknowns, and removing one can provide control and peace of mind to a soon-to-be mom, reducing potential stress and anxiety.

Gateway Genomics, leading developer of direct-to-consumer genetic tests that give families insight into their future children, announces a new publication titled, “Reported Benefits of Early Fetal Sex Determination” in the International Journal of Pregnancy & Child Birth. In the study, over 1,000 postpartum moms who had taken the SneakPeek Early Gender DNA Test responded to a survey to share what benefits they received from knowing the gender of their babies early in pregnancy.

Annually, 83% of women who give birth are millennials, and 68% of this group are interested in knowing their baby’s gender prior to birth. The typical method of learning fetal sex is through the anatomy ultrasound conducted at 18 to 22 weeks into pregnancy. However, the women in this study chose to learn the gender of their babies as early as 8 weeks into pregnancy with SneakPeek, a 99.1% accurate direct-to-consumer DNA test that can be taken either from the comfort of home or at a clinical location.

“Learning the gender of your baby early is a very personal choice,” says Gateway Genomics CEO, Chris Jacob. “Some health insurance companies have stated that fetal sex information is not medically necessary and therefore doesn’t need to be made widely available, but from our interactions with customers, we found that parents gain immense benefits from knowing if they’re having a boy or girl early in pregnancy. We decided to validate this with a formal study to advocate for families who want this knowledge early in pregnancy and highlight the positive benefits that can be gained from this information.”

Gateway Genomics sent a survey to postpartum mothers who had taken the SneakPeek Early Gender DNA Test to ask what benefits they received from knowing their baby’s gender as early as 8 weeks into pregnancy. The survey received 1,129 responses, and the top 7 reasons were:

1)    Satisfied my curiosity (93%)

2)    Helped me shop for baby (81%)

3)    Helped me name baby (80%)

4)    Let grandparents or other relatives know (72%)

5)    Helped me and my partner bond and connect with baby (53-56%)

6)    Gave me a sense of control and peace of mind (51%)

7)    Let me announce to loved ones through email or social media (40-49%)

In pregnancy, there are many unknowns, and being able to remove one can provide a sense of control and peace of mind to a soon-to-be mom, reducing potential stress and anxiety. Knowing boy or girl made the baby more tangible for some, allowing for better bonding and quenched curiosity. The SneakPeek test also enabled enhanced planning, providing parents with a larger window of time to shop and consider names for the new baby. Lastly, knowing fetal sex created an additional opportunity to share the joy of a new life; many parents announced the gender to grandparents, other relatives, and friends.

“This study was conducted with participants from the US, UK, and Canada,” continues Mr. Jacob. “There are concerns in some areas of the world that an early fetal sex determination test would enable gender selection, but we didn’t see this reflected in the responses from participants in these three countries. This opens the opportunity for early fetal sex determination to be offered more widely in the US, UK, and Canada, for the benefit of parents and their new children.”

In 2019, Gateway Genomics ranked #236 in the 38th annual Inc. 500|5000 list of fastest-growing private companies in the U.S., #23 in the Health sector. In this year’s Inc. 5000 California list, the company was ranked the 17th fastest-growing private company in the state, and #1 in the Health sector. Gateway Genomics’ principal product, SneakPeek, is an easy-to-use DNA test that lets parents know the gender of their babies as early as 8 weeks into pregnancy, with 99.1% accuracy.

About Gateway Genomics

Gateway Genomics is a personal genomics company with the mission to develop leading-edge genetic tests that give families a new level of understanding about their future children. Since inception, more than 250,000 SneakPeek Early Gender DNA tests have been provided to help new parents bond with their babies, make plans, and connect with friends and family around them. Gateway Genomics is located in La Jolla, CA.

Share article on social media or email:

Slone Partners Names Leadership Expert Mary Stutts to Company Advisory Board


News Image

Stutts remarked, “I will bring my voice, perspective and insights as a seasoned black female executive to the table, and help solidify Slone’s leadership and commitment to diversity and inclusion, both within the company and within the candidate pools that we deliver to our client partners.”

Mary Stutts, has been named to the Advisory Board of Slone Partners, it was announced today. Stutts is a renowned C-level global branding and growth expert who has provided strategic counsel in the biotechnology, healthcare, technology, and media industries at Fortune 200 companies including Genentech, Bayer, Bristol Myers Squibb, Kaiser Permanente, UnitedHealth Group, and Comcast NBCUniversal. Mary Stutts is currently the Senior Vice President, Corporate Relations at Sumitovant Biopharma.

Growing up as a foster child from the age of five, Stutts in 2004 founded The Center for Excellence in Life (TCEL), a 501c3 organization focused on developing women and underrepresented youth aspiring to leadership positions. She later served as Chief Inclusion, Diversity & Health Equity Officer at Stanford Health Care (SHC), where she worked directly with the SHC Board of Directors and executive committee to build and curate an Inclusive Leadership Program for Stanford’s leaders.

Stutts joins Vijay Aggarwal, Ph.D., Bijan Salehizadeh, M.D., Mara G. Aspinall, and Kyle Wilson as members of the Advisory Board of Slone Partners.

“Mary Stutts brings many years of life sciences business leadership experience and perspectives to our firm at a time when we are renewing its commitment to diversity and inclusion,” said Slone Partners President Tara Kochis-Stach. “I believe that Mary will help shape the future of Slone Partners as we continue to grow and improve the level of service that we provide to our client partners and candidates.”

Stutts remarked, “I am honored and delighted to become a member of the Advisory Board of Slone Partners as I am a firm believer in the company’s mission and its people. In my role, I will bring my voice, perspective and insights as a seasoned black female executive to the table, and help solidify Slone’s leadership and commitment to diversity and inclusion, both within the company and within the candidate pools that we deliver to our client partners.”

Stutts is a highly-respected corporate advisor, author, and speaker on the dynamics of women and men in leadership, developing a personal brand, mastering entrepreneurship, and the imperative for women leaders to add value in growing corporations. Her current book, “The Missing Mentor: Women Advising Women on Power, Progress and Priorities,” is regularly listed among the top sellers on the topic of women in leadership. Named one of Savoy Magazine’s 2019 Most Influential Women in Corporate America, Stutts earned a B.A. in Communications Management from the University of Louisiana, a Master’s Degree in Health Administration from the University of Southern California, and completed the Executive Program on Organization and Strategy at the Stanford Graduate School of Business.

ABOUT SLONE PARTNERS

Slone Partners delivers the leaders who build amazing scientific healthcare organizations – People Are Our Science®. Since 2000, Slone Partners specializes in delivering world-class C-suite leadership, executive, and upper management talent to the most promising and established life sciences, biotechnology, diagnostics, precision medicine, CRO, and laboratory services companies. With coast-to-coast presence in the most active healthcare industry hubs of Boston, San Francisco, Los Angeles, San Diego, Austin, Research Triangle Park NC, and Washington DC, Slone Partners uniquely and precisely provides an array of executive search and advisory services to innovative scientific healthcare companies. To learn more about Slone Partners’ value proposition and processes, visit http://www.slonepartners.com or call 888.784.3422.

Share article on social media or email:

SIUE Nurse Educator Program Tabbed #1 in Illinois, #7 in Nation


SIUE School of Nursing’s Andrew Griffin, PhD, CRNA, APRN, assistant dean for graduate programs.

“Our focus has been to provide high-quality courses and curricula, while maximizing learner flexibility and affordability.”

Southern Illinois University Edwardsville School of Nursing’s premier programming is again being nationally recognized. EduMed’s 2020 ranking of Best Online Master’s Programs in Nursing Education tabs SIUE’s completely online nurse educator program #1 in Illinois and #7 in the nation.

EduMed’s ranking methodology considers programs with proper accreditation that boast an exemplary combination of affordability, quality and flexibility.

“We have worked intensely in the School of Nursing to find the perfect balance for our graduate programs,” said Andrew Griffin, PhD, CRNA, APRN, assistant dean for graduate programs in the SIUE SON. “Our focus has been to provide high-quality courses and curricula, while maximizing learner flexibility and affordability. We have seen tremendous growth in our graduate student population. National rankings such as this prove we are accomplishing our goals.”

“The faculty have worked diligently to plan and deliver an up-to-date curriculum that prepares our graduates for nurse educator positions in both academic and healthcare settings,” said Kay Gaehle, PhD, RN, associate professor and coordinator of the nurse educator program. “Our completely online program is affordable, flexible and high quality. As students progress through the program, they are challenged to apply what they have learned, so that the final outcome is that each student is prepared for taking on the role of a graduate level nurse educator.”

According to Gaehle, there is a shortage of nurse educators, particularly in academic settings. In order to educate entry level staff nurses, master’s prepared nurse educators are needed to teach in undergraduate nursing programs, as well as help new graduates make the transition into the role of the new nurse in acute care settings.

SIUE’s program provides a strong foundation for both nurse educators in academic as well as acute care settings. The SON nurse educator master’s program offers students three face-to-face applied learning opportunities working with preceptors in education, university and hospital-based settings at convenient locations that are selected to meet the individual academic needs, interests and professional experience of each student.

After finishing the program and gaining two years of teaching experience, graduates are eligible to take the National League for Nursing Certified Nurse Educator exam. The SON’s nurse educator post-master’s certificate offers coursework that prepares students with theory preparation for the national certification examination.

For more information on SIUE’s nurse educator master’s program, visit siue.edu/nurse-educator.

The SIUE School of Nursing’s programs are committed to creating excellence in nursing leadership through innovative teaching, evidence-based practice, quality research, patient advocacy and community service. Enrolling more than 1,700 students in its baccalaureate, master’s and doctoral programs, the School develops leaders in pursuit of shaping the nursing profession and impacting the health care environment. SIUE’s undergraduate nursing programs on the Edwardsville campus and the regional campus in Carbondale help to solve the region’s shortage of baccalaureate-prepared nurses and enhance the quality of nursing practice within all patient service venues. The School’s graduate programs prepare nurses for advanced roles in clinical practice, administration and education.

Share article on social media or email:

Trident at AIU Welcomes Experienced Scholar-Practitioner to its DHA Program


Dr. Renee Hotchkiss Geschke, Full-time Professor, Trident

Trident at American InterContinental University (Trident) is happy to welcome Full-time Professor Dr. Renee Hotchkiss Geschke to the College of Health and Human Services. She will be teaching in the University’s new Doctor of Health Administration (DHA) program.

In this role Dr. Hotchkiss Geschke will be leading the curriculum development for the DHA program, mentoring doctoral students, chairing Doctoral Study Project (DSP) committees, and engaging in scholarly research. She brings a strong background in interdisciplinary practice and research, which will be beneficial to doctoral students who are pursuing similar professional and academic paths.

Dr. Hotchkiss Geschke’s research interests are related to health administration, health services, health policy, and public health. She is well-versed in applied research, covering topics like the impact of volunteerism on hospital performance, cost-benefit analyses of health programs, and the economic impacts of health disparities.

Academic outlets where Dr. Hotchkiss Geschke’s research has been published include Journal of American College Health, Journal of Health Administration Education, International Journal of Public Policy, Health Care Management Review, and Nonprofit and Voluntary Sector Quarterly. Her work has been included in the conference proceedings of the Academy of Management and the Global Business and Technology Association.

Her previous academic leadership roles include Lead Faculty – Healthcare Management at Colorado Technical University, Associate Professor and Program Director at Rollins College, and Associate Professor and Program Director at Florida Gulf Coast University. She was also an Associate Professor at Georgia Southern University, where she instructed public health courses at the doctoral level and performed scholarly research.

Dr. Hotchkiss Geschke holds a Ph.D. in Public Affairs from University of Central Florida, where she also earned a Master of Science in Health Services Administration and a Bachelor of Science in Health Services Administration.

About Trident at American InterContinental University

Founded in 1998, Trident at American InterContinental University (Trident at AIU) is part of an online postsecondary university serving adult learners. Trident at AIU uses the EdActive™ learning approach, which employs case-based learning in an online setting to teach real-world relevant critical thinking skills designed to enhance the lives and education of students. Trident offers quality associate, bachelor’s, master’s, and doctoral degree programs and certificates, led by a qualified faculty team, over 80% of whom have doctoral degrees. Trident at AIU is regionally accredited by the Higher Learning Commission (hlcommission.org) and has more than 22,000 alumni with a military affiliation. Trident has received acknowledgements from Washington Monthly, Military Times, and Military Advanced Education & Transition for their dedication to student success. Visit http://www.trident.edu or call at (855) 290-0290 to learn more about Trident at AIU’s wide range of educational options.

Share article on social media or email:

Transform Quality and Compliance Webinar July 30, 2020


WCG FDAnews

WCG FDAnews

Blockchain Systems in Pharmaceuticals

Transform Quality and Compliance

An FDAnews Webinar

Thursday, July 30, 2020, 1:30-3:30 p.m. EDT

https://www.fdanews.com/blockchainsystems

Blockchains are revolutionizing the pharmaceutical industry, simplifying existing processes for data integrity. These secure databases keep track of all transactions — concept, pre-clinical testing, phase I, II, III trials, approvals, postmarket surveillance, drug supply chain — in a single system.

To stay competitive, one needs to understand the core tenets of distributed systems, blockchains and cryptography. James Canterbury — a partner in Ernst & Young’s Risk Advisory practice where he works with the global blockchain team — will lay the foundation to leverage these systems:


  • Highlights of where blockchains are currently being used in the pharmaceutical industry, including manufacturing and the supply chain
  • The core components of blockchain technology, including single-source data integrity
  • Public vs. private blockchains and the challenges, advantages and disadvantages of each
  • How to use a blockchain as a notarization system
  • The role of non-fungible tokens in product track and trace in the COVID-19 era and beyond

Put blockchain to work for teh company to streamline processes, improve quality, ensure compliance and simplify data integrity.

Interested in registering multiple sites?

Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally

to learn about our special multisite discount.

Webinar Details:

Blockchain Systems in Pharmaceuticals

Transform Quality and Compliance

An FDAnews Webinar

Thursday, July 30, 2020, 1:30-3:30 p.m. EDT

https://www.fdanews.com/blockchainsystems

Tuition:

$287 per site

Easy Ways to Register:

Online: https://www.fdanews.com/blockchainsystems

By phone: 888.838.5578 or 703.538.7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations

Share article on social media or email:

KOAMTAC Augments Line of Barcode Scanners, RFID Readers, and mPOS with Social Distancing Solution


KOAMTAC, Inc. a leading manufacturer of Bluetooth companion barcode scanners, barcode and RFID Sleds, mPOS solutions, and enterprise charging solutions today launched a social distance solution for KDC BLE 5.0 barcode scanners and RFID readers. With warehouses, manufacturing, and other businesses resuming globally, the solution helps businesses adhere to social distancing guidelines and therefore protect employees’ health.

The new proximity feature leverages Bluetooth Low Energy (BLE) 5.0 to alert employees via loud beeping alert, social distance warning message on screen, and vibration of both the KDC device and phone or tablet host device. The combination of approaches was created to help social distance even in a loud work environment and ensure accessibility for all workers. Workers may continue to utilize the scanner when the proximity sensor is alerting them, however, the alarm and messaging will continue until employees are at a safe, predetermined distance.

“As we return to work in our warehouses and manufacturing line, we have our employees’ health at the forefront. Proximity alerting is an excellent way to ensure they maintain a safe distance in these environments. We understood that if we wanted proximity alerts, so, too, would our customers,” said Hanjin Lee, President of KOAMTAC.

The proximity alert can be defined using the menu on a BLE 5.0 KDC, via KTSync application, or by scanning a special barcode and can be adjusted in increments of 3.3 feet (1 meter) up to 16 feet (5 meters). It is available for all BLE 5.0 KDC models including those with inductive charging, an alphanumeric keypad, and RFID reader. The KDC will send a notification to the connected host device, where it will record violations throughout the work shift and be available for review by supervisors. Utilizing the KTSync application, each violation can also trigger an email to the supervisor in real time to ensure adherence to the company’s social distance policy.

The proximity alert for social distancing is available to all current KOAMTAC customers via the latest firmware available for download at https://koamtac.com/support/downloads/firmware/. No additional software or application is needed to apply it to BLE KDCs though utilizing the KTSync app provides advanced options including warnings on the host device and automated supervisor notifications. For help with upgrading firmware, customers can contact KOAMTAC customer support via phone +1.609.256.4700 or online at https://koamtac.com/social-distancing-solution/.

Customers with Bluetooth Classic KDCs or KDCs with BLE4.1 can contact KOAMTAC to discuss upgrading their devices to BLE 5.0 models. KOAMTAC’s future proximity alerts will also be available via their KOAMTACON Mobile Data Management App with a dashboard for holistic reporting and contact tracing. KOAMTAC is also working on a consumer-level social distancing proximity alert solution utilizing BLE dongles and tags as a low-cost safety solution for businesses open to the public.

ABOUT KOAMTAC

KOAMTAC, Inc., headquartered in Princeton, NJ, is focused on empowering data capture in the mobile world for warehousing, healthcare, retail, ecommerce, transportation and logistics, manufacturing, and other industries. With solutions for barcode scanning, RFID reading, mobile point of sale (mPOS), and enterprise charging made for both Android and iOS and in peripheral/companion, sled, and wearable formats, KOAMTAC is the most versatile solution partner on the market today. For more information, visit http://www.koamtac.com, email the team at info@koamtac.com, or call +16092564700. Join in on the conversation on Facebook (https://facebook.com/koamtac), Twitter (https://twitter.com/koamtac), LinkedIn (https://linkedin.com/company/koamtac), and YouTube (https://youtube.com/koamtac) and sign up for our newsletter to stay updated on the latest products and announcements.

Share article on social media or email: